| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abbreviated scan protocols to capture 18F-FDG kinetics for long axial FOV PET scanners
|
Viswanath, Varsha
|
|
|
49 |
Suppl 1 |
p. 3215-3225
|
artikel
|
| 2 |
Abdominal obesity, and not general obesity, is associated with a lower 123I MIBG heart-to-mediastinum ratio in heart failure patients with preserved ejection fraction
|
Sunaga, Akihiro
|
|
|
49 |
Suppl 1 |
p. 609-618
|
artikel
|
| 3 |
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
|
Eertink, J. J.
|
|
|
49 |
Suppl 1 |
p. 943-952
|
artikel
|
| 4 |
Accurate detection of intracranial extension of jugulotympanic paraganglioma by [18F]FDOPA-PET/CT comparing to MRI
|
Araghi, Zahra Jamshidi
|
|
|
49 |
Suppl 1 |
p. 412-414
|
artikel
|
| 5 |
A clinical study of a CD44v6-targeted fluorescent agent for the detection of non-muscle invasive bladder cancer
|
Shang, Wenting
|
|
|
49 |
Suppl 1 |
p. 3033-3045
|
artikel
|
| 6 |
A comparison of advanced semi-quantitative amyloid PET analysis methods
|
Peira, Enrico
|
|
|
49 |
Suppl 1 |
p. 4097-4108
|
artikel
|
| 7 |
A cross-scanner and cross-tracer deep learning method for the recovery of standard-dose imaging quality from low-dose PET
|
Xue, Song
|
|
|
49 |
Suppl 1 |
p. 1843-1856
|
artikel
|
| 8 |
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
|
Öcal, Osman
|
|
|
49 |
Suppl 1 |
p. 4716-4726
|
artikel
|
| 9 |
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
|
Lam, Marnix
|
|
|
49 |
Suppl 1 |
p. 3340-3352
|
artikel
|
| 10 |
A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [18F]SDM-16
|
Zheng, Chao
|
|
|
49 |
Suppl 1 |
p. 1482-1496
|
artikel
|
| 11 |
Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting
|
Johnsson, Kerstin
|
|
|
49 |
Suppl 1 |
p. 1041-1051
|
artikel
|
| 12 |
An [18F]FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients
|
Wallis, David
|
|
|
49 |
Suppl 1 |
p. 881-888
|
artikel
|
| 13 |
Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy
|
Xue, Song
|
|
|
49 |
Suppl 1 |
p. 4064-4072
|
artikel
|
| 14 |
A prospective head-to-head comparison of 68 Ga-NOTA-3P-TATE-RGD and 68 Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours
|
Jiang, Yuanyuan
|
|
|
49 |
Suppl 1 |
p. 4218-4227
|
artikel
|
| 15 |
A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE
|
Zhu, Wenjia
|
|
|
49 |
Suppl 1 |
p. 1613-1622
|
artikel
|
| 16 |
A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model
|
Kimura, Taeko
|
|
|
49 |
Suppl 1 |
p. 4298-4311
|
artikel
|
| 17 |
Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT
|
Weyts, Kathleen
|
|
|
49 |
Suppl 1 |
p. 3750-3760
|
artikel
|
| 18 |
Artificial intelligence guided enhancement of digital PET: scans as fast as CT?
|
Hosch, René
|
|
|
49 |
Suppl 1 |
p. 4503-4515
|
artikel
|
| 19 |
A self-triggered radioligand therapy agent for fluorescence imaging of the treatment response in prostate cancer
|
Xu, Hongchuang
|
|
|
49 |
Suppl 1 |
p. 2693-2704
|
artikel
|
| 20 |
A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [18F]FDG PET-CT studies performed in oncologic patients
|
Cohen, Dan
|
|
|
49 |
Suppl 1 |
p. 1338-1344
|
artikel
|
| 21 |
Assessment of malignancy and PSMA expression of uncertain bone foci in [18F]PSMA-1007 PET/CT for prostate cancer—a single-centre experience of PET-guided biopsies
|
Vollnberg, Bernd
|
|
|
49 |
Suppl 1 |
p. 3910-3916
|
artikel
|
| 22 |
Assessment of the routine reporting of very low-dose exercise-first myocardial perfusion SPECT from a large-scale real-world cohort and correlation with the subsequent reporting of coronary stenosis at angiography
|
Chawki, Mohammad B.
|
|
|
49 |
Suppl 1 |
p. 1223-1231
|
artikel
|
| 23 |
A two-stage cardiac PET and late gadolinium enhancement MRI co-registration method for improved assessment of non-ischemic cardiomyopathies using integrated PET/MR
|
Zhang, Zheng
|
|
|
49 |
Suppl 1 |
p. 2199-2208
|
artikel
|
| 24 |
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up
|
Hartrampf, Philipp E.
|
|
|
49 |
Suppl 1 |
p. 4262-4270
|
artikel
|
| 25 |
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
|
Yang, Shan-Shan
|
|
|
49 |
Suppl 1 |
p. 980-991
|
artikel
|
| 26 |
Can Q.Clear reconstruction be used to improve [68 Ga]Ga-DOTANOC PET/CT image quality in overweight NEN patients?
|
Zanoni, Lucia
|
|
|
49 |
Suppl 1 |
p. 1607-1612
|
artikel
|
| 27 |
Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by 18F-FDG total-body PET/CT imaging?
|
Xiao, Jie
|
|
|
49 |
Suppl 1 |
p. 269-278
|
artikel
|
| 28 |
Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy
|
Huang, Wenhui
|
|
|
49 |
Suppl 1 |
p. 4427-4439
|
artikel
|
| 29 |
CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing
|
Mancini, Laura
|
|
|
49 |
Suppl 1 |
p. 2377-2391
|
artikel
|
| 30 |
Characterization in nonhuman primates of (R)-[18F]OF-Me-NB1 and (S)-[18F]OF-Me-NB1 for imaging the GluN2B subunits of the NMDA receptor
|
Zheng, MingQiang
|
|
|
49 |
Suppl 1 |
p. 2153-2162
|
artikel
|
| 31 |
Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma—a retrospective cohort study
|
Kagan, Kim Ben Tikva
|
|
|
49 |
Suppl 1 |
p. 2290-2299
|
artikel
|
| 32 |
Clinical significance of 123I-BMIPP washout rate in patients with uncertain chronic heart failure
|
Aoshima, Chihiro
|
|
|
49 |
Suppl 1 |
p. 3129-3139
|
artikel
|
| 33 |
Clozapine induces astrocyte-dependent FDG-PET hypometabolism
|
Rocha, Andréia
|
|
|
49 |
Suppl 1 |
p. 2251-2264
|
artikel
|
| 34 |
Comparing the clinical performance and cost efficacy of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis
|
Alberts, Ian
|
|
|
49 |
Suppl 1 |
p. 4252-4261
|
artikel
|
| 35 |
Comparison of deep learning-based emission-only attenuation correction methods for positron emission tomography
|
Hwang, Donghwi
|
|
|
49 |
Suppl 1 |
p. 1833-1842
|
artikel
|
| 36 |
Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the detection of primary and metastatic lesions in patients with gastric cancer: a bicentric retrospective study
|
Jiang, Donglang
|
|
|
49 |
Suppl 1 |
p. 732-742
|
artikel
|
| 37 |
Correction to: Hetero-bivalent agents targeting FAP and PSMA
|
Boinapally, Srikanth
|
|
|
49 |
Suppl 1 |
p. 4755
|
artikel
|
| 38 |
Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with 18F-SynVesT-1 positron emission tomography imaging
|
Tang, Yongxiang
|
|
|
49 |
Suppl 1 |
p. 3482-3491
|
artikel
|
| 39 |
64Cu-labeled daratumumab F(ab′)2 fragment enables early visualization of CD38-positive lymphoma
|
Kang, Lei
|
|
|
49 |
Suppl 1 |
p. 1470-1481
|
artikel
|
| 40 |
Current status and quality of radiomic studies for predicting immunotherapy response and outcome in patients with non-small cell lung cancer: a systematic review and meta-analysis
|
Chen, Qiuying
|
|
|
49 |
Suppl 1 |
p. 345-360
|
artikel
|
| 41 |
Cyclotron production of 225Ac from an electroplated 226Ra target
|
Nagatsu, Kotaro
|
|
|
49 |
Suppl 1 |
p. 279-289
|
artikel
|
| 42 |
Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning
|
Zhao, Yu
|
|
|
49 |
Suppl 1 |
p. 2798-2811
|
artikel
|
| 43 |
Decoupling of regional neural activity and inter-regional functional connectivity in Alzheimer’s disease: a simultaneous PET/MR study
|
Maleki Balajoo, Somayeh
|
|
|
49 |
Suppl 1 |
p. 3173-3185
|
artikel
|
| 44 |
Decrease in the cortex/striatum metabolic ratio on [18F]-FDG PET: a biomarker of autoimmune encephalitis
|
De Leiris, Nicolas
|
|
|
49 |
Suppl 1 |
p. 921-931
|
artikel
|
| 45 |
Deep learning–based attenuation correction for whole-body PET — a multi-tracer study with 18F-FDG, 68 Ga-DOTATATE, and 18F-Fluciclovine
|
Toyonaga, Takuya
|
|
|
49 |
Suppl 1 |
p. 3086-3097
|
artikel
|
| 46 |
Deep learning–based denoising of low-dose SPECT myocardial perfusion images: quantitative assessment and clinical performance
|
Aghakhan Olia, Narges
|
|
|
49 |
Suppl 1 |
p. 1508-1522
|
artikel
|
| 47 |
Deep learning–based time-of-flight (ToF) image enhancement of non-ToF PET scans
|
Mehranian, Abolfazl
|
|
|
49 |
Suppl 1 |
p. 3740-3749
|
artikel
|
| 48 |
Deep learning radiomics of dual-energy computed tomography for predicting lymph node metastases of pancreatic ductal adenocarcinoma
|
An, Chao
|
|
|
49 |
Suppl 1 |
p. 1187-1199
|
artikel
|
| 49 |
Development and comparison of three 89Zr-labeled anti-CLDN18.2 antibodies to noninvasively evaluate CLDN18.2 expression in gastric cancer: a preclinical study
|
Hu, Guilan
|
|
|
49 |
Suppl 1 |
p. 2634-2644
|
artikel
|
| 50 |
Diagnostic performance of deep learning models for detecting bone metastasis on whole-body bone scan in prostate cancer
|
Han, Sangwon
|
|
|
49 |
Suppl 1 |
p. 585-595
|
artikel
|
| 51 |
Diagnostic performance of [18F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis
|
Mirshahvalad, Seyed Ali
|
|
|
49 |
Suppl 1 |
p. 4205-4217
|
artikel
|
| 52 |
Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT
|
Hu, Yan
|
|
|
49 |
Suppl 1 |
p. 3538-3546
|
artikel
|
| 53 |
Direct and indirect strategies of deep-learning-based attenuation correction for general purpose and dedicated cardiac SPECT
|
Chen, Xiongchao
|
|
|
49 |
Suppl 1 |
p. 3046-3060
|
artikel
|
| 54 |
Direct inference of Patlak parametric images in whole-body PET/CT imaging using convolutional neural networks
|
Zaker, Neda
|
|
|
49 |
Suppl 1 |
p. 4048-4063
|
artikel
|
| 55 |
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens
|
Cytawa, Wojciech
|
|
|
49 |
Suppl 1 |
p. 3938-3949
|
artikel
|
| 56 |
DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with 131I
|
Schumann, S.
|
|
|
49 |
Suppl 1 |
p. 1447-1455
|
artikel
|
| 57 |
Dose–response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastases
|
Ebbers, Sander C.
|
|
|
49 |
Suppl 1 |
p. 1700-1710
|
artikel
|
| 58 |
Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity
|
Kratochwil, Clemens
|
|
|
49 |
Suppl 1 |
p. 54-63
|
artikel
|
| 59 |
Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study
|
Qiu, Dong-Xu
|
|
|
49 |
Suppl 1 |
p. 2821-2832
|
artikel
|
| 60 |
EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data
|
van Sluis, Joyce
|
|
|
49 |
Suppl 1 |
p. 4652-4660
|
artikel
|
| 61 |
Effects of MRI protocols on brain FDG uptake in simultaneous PET/MR imaging
|
Wang, Jingjuan
|
|
|
49 |
Suppl 1 |
p. 2812-2820
|
artikel
|
| 62 |
Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study
|
Yadav, Madhav Prasad
|
|
|
49 |
Suppl 1 |
p. 1595-1606
|
artikel
|
| 63 |
Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study
|
Clement, Dominique
|
|
|
49 |
Suppl 1 |
p. 3529-3537
|
artikel
|
| 64 |
Eribulin improves tumor oxygenation demonstrated by 18F-DiFA hypoxia imaging, leading to radio-sensitization in human cancer xenograft models
|
Bo, Tomoki
|
|
|
49 |
Suppl 1 |
p. 821-833
|
artikel
|
| 65 |
Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG
|
Chen, Wanqi
|
|
|
49 |
Suppl 1 |
p. 4145-4155
|
artikel
|
| 66 |
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
|
Ceci, Francesco
|
|
|
49 |
Suppl 1 |
p. 3257-3268
|
artikel
|
| 67 |
18F-Alfatide II for the evaluation of axillary lymph nodes in breast cancer patients: comparison with 18F-FDG
|
Wu, Jiang
|
|
|
49 |
Suppl 1 |
p. 2869-2876
|
artikel
|
| 68 |
FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies
|
Dendl, K.
|
|
|
49 |
Suppl 1 |
p. 721-731
|
artikel
|
| 69 |
Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy
|
Zhang, Pu
|
|
|
49 |
Suppl 1 |
p. 1985-1996
|
artikel
|
| 70 |
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis
|
Chen, Shih-hsin
|
|
|
49 |
Suppl 1 |
p. 371-384
|
artikel
|
| 71 |
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
|
de Koster, Elizabeth J.
|
|
|
49 |
Suppl 1 |
p. 3452-3469
|
artikel
|
| 72 |
[18F]DPA-714 PET imaging for the quantitative evaluation of early spatiotemporal changes of neuroinflammation in rat brain following status epilepticus
|
Kaneko, Ken-ichi
|
|
|
49 |
Suppl 1 |
p. 2265-2275
|
artikel
|
| 73 |
Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
|
Unterrainer, Lena M.
|
|
|
49 |
Suppl 1 |
p. 3571-3580
|
artikel
|
| 74 |
Feasibility of in vivo CAR T cells tracking using streptavidin–biotin-paired positron emission tomography
|
Pan, Donghui
|
|
|
49 |
Suppl 1 |
p. 4419-4426
|
artikel
|
| 75 |
Federico Caobelli (Ed): Imaging of Inflammation and Infection in Cardiovascular Diseases
|
Mansi, Luigi
|
|
|
49 |
Suppl 1 |
p. 423
|
artikel
|
| 76 |
[18F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [68Ga]Ga-FAPI-04
|
Hu, Kongzhen
|
|
|
49 |
Suppl 1 |
p. 2833-2843
|
artikel
|
| 77 |
[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma
|
Vos, Joris L.
|
|
|
49 |
Suppl 1 |
p. 2010-2022
|
artikel
|
| 78 |
[18F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort
|
Lovinfosse, P.
|
|
|
49 |
Suppl 1 |
p. 331-335
|
artikel
|
| 79 |
[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies
|
Cohen, Dan
|
|
|
49 |
Suppl 1 |
p. 953-962
|
artikel
|
| 80 |
[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial
|
de Koster, Elizabeth J.
|
|
|
49 |
Suppl 1 |
p. 1970-1984
|
artikel
|
| 81 |
18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum
|
Moscoso, Alexis
|
|
|
49 |
Suppl 1 |
p. 1242-1253
|
artikel
|
| 82 |
[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial
|
Zanoni, Lucia
|
|
|
49 |
Suppl 1 |
p. 390-409
|
artikel
|
| 83 |
Fibrin-targeting molecular MRI in inflammatory CNS disorders
|
Lohmeier, Johannes
|
|
|
49 |
Suppl 1 |
p. 3692-3704
|
artikel
|
| 84 |
Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging
|
Xie, Boqia
|
|
|
49 |
Suppl 1 |
p. 2786-2797
|
artikel
|
| 85 |
Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model
|
Liu, Yuwei
|
|
|
49 |
Suppl 1 |
p. 871-880
|
artikel
|
| 86 |
First experiences with dynamic renal [68Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate
|
Kersting, David
|
|
|
49 |
Suppl 1 |
p. 3373-3386
|
artikel
|
| 87 |
First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients
|
Sari, Hasan
|
|
|
49 |
Suppl 1 |
p. 1997-2009
|
artikel
|
| 88 |
18F- or 177Lu-labeled bivalent ligand of fibroblast activation protein with high tumor uptake and retention
|
Li, Hongsheng
|
|
|
49 |
Suppl 1 |
p. 2705-2715
|
artikel
|
| 89 |
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
|
Trägårdh, Elin
|
|
|
49 |
Suppl 1 |
p. 3412-3418
|
artikel
|
| 90 |
[68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET/CT
|
Lin, Rong
|
|
|
49 |
Suppl 1 |
p. 2960-2971
|
artikel
|
| 91 |
[68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity
|
Rosenkrans, Zachary T.
|
|
|
49 |
Suppl 1 |
p. 3705-3716
|
artikel
|
| 92 |
[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease
|
Conen, Patrick
|
|
|
49 |
Suppl 1 |
p. 3365-3372
|
artikel
|
| 93 |
[68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatment
|
Peters, Steffie M. B.
|
|
|
49 |
Suppl 1 |
p. 1101-1112
|
artikel
|
| 94 |
68Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent
|
Duan, Xiaojiang
|
|
|
49 |
Suppl 1 |
p. 1030-1040
|
artikel
|
| 95 |
Galectin expression detected by 68Ga-galectracer PET as a predictive biomarker of radiotherapy resistance
|
Lu, Dehua
|
|
|
49 |
Suppl 1 |
p. 2746-2760
|
artikel
|
| 96 |
Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management
|
Qin, Chunxia
|
|
|
49 |
Suppl 1 |
p. 4228-4240
|
artikel
|
| 97 |
68Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement
|
Chavoshi, Mohammadreza
|
|
|
49 |
Suppl 1 |
p. 1021-1029
|
artikel
|
| 98 |
GPC3-targeted immunoPET imaging of hepatocellular carcinomas
|
An, Shuxian
|
|
|
49 |
Suppl 1 |
p. 2682-2692
|
artikel
|
| 99 |
Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies
|
Chauveau, Fabien
|
|
|
49 |
Suppl 1 |
p. 201-220
|
artikel
|
| 100 |
Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients
|
Wang, Guochang
|
|
|
49 |
Suppl 1 |
p. 1052-1062
|
artikel
|
| 101 |
Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer
|
Lawal, Ismaheel O.
|
|
|
49 |
Suppl 1 |
p. 3581-3592
|
artikel
|
| 102 |
Hetero-bivalent agents targeting FAP and PSMA
|
Boinapally, Srikanth
|
|
|
49 |
Suppl 1 |
p. 4369-4381
|
artikel
|
| 103 |
Hot needles can confirm accurate lesion sampling intraoperatively using [18F]PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer
|
Ferraro, Daniela A.
|
|
|
49 |
Suppl 1 |
p. 1721-1730
|
artikel
|
| 104 |
Hybrid total-body pet scanners—current status and future perspectives
|
Nadig, Vanessa
|
|
|
49 |
Suppl 1 |
p. 445-459
|
artikel
|
| 105 |
Imaging joint infections using D-methyl-11C-methionine PET/MRI: initial experience in humans
|
Polvoy, Ilona
|
|
|
49 |
Suppl 1 |
p. 3761-3771
|
artikel
|
| 106 |
Imaging of cardiac fibroblast activation in patients with chronic thromboembolic pulmonary hypertension
|
Chen, Bi-Xi
|
|
|
49 |
Suppl 1 |
p. 1211-1222
|
artikel
|
| 107 |
Imaging PARP with [18F]rucaparib in pancreatic cancer models
|
Chan, Chung Ying
|
|
|
49 |
Suppl 1 |
p. 3668-3678
|
artikel
|
| 108 |
Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET)
|
Rossano, Samantha
|
|
|
49 |
Suppl 1 |
p. 3679-3691
|
artikel
|
| 109 |
ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer
|
Chen, Weiyu
|
|
|
49 |
Suppl 1 |
p. 861-870
|
artikel
|
| 110 |
Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands
|
Tschan, Viviane J.
|
|
|
49 |
Suppl 1 |
p. 470-480
|
artikel
|
| 111 |
Improved myocardial blood flow estimation with residual activity correction and motion correction in 18F-flurpiridaz PET myocardial perfusion imaging
|
Otaki, Yuka
|
|
|
49 |
Suppl 1 |
p. 1881-1893
|
artikel
|
| 112 |
Incidence rate and factors associated with the development of secondary cancers after radioiodine therapy in differentiated thyroid cancer: a multicenter retrospective study
|
Hong, Chae Moon
|
|
|
49 |
Suppl 1 |
p. 1661-1670
|
artikel
|
| 113 |
Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond
|
Qin, Chunxia
|
|
|
49 |
Suppl 1 |
p. 709-720
|
artikel
|
| 114 |
Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients
|
Minczeles, Noémie S.
|
|
|
49 |
Suppl 1 |
p. 3203-3214
|
artikel
|
| 115 |
Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI
|
Laudicella, Riccardo
|
|
|
49 |
Suppl 1 |
p. 3917-3928
|
artikel
|
| 116 |
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy
|
Syguła, Aleksandra
|
|
|
49 |
Suppl 1 |
p. 3841-3851
|
artikel
|
| 117 |
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial
|
Rühle, Alexander
|
|
|
49 |
Suppl 1 |
p. 1650-1660
|
artikel
|
| 118 |
Intra-articular use of radium dichloride ([223Ra] RaCl2) showed relevant anti-inflammatory response on experimental arthritis model
|
Corrêa, Luana Barbosa
|
|
|
49 |
Suppl 1 |
p. 336-344
|
artikel
|
| 119 |
Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection
|
Jonker, Pascal K. C.
|
|
|
49 |
Suppl 1 |
p. 3557-3570
|
artikel
|
| 120 |
Intraoperative near-infrared fluorescence imaging can identify pelvic nerves in patients with cervical cancer in real time during radical hysterectomy
|
He, Kunshan
|
|
|
49 |
Suppl 1 |
p. 2929-2937
|
artikel
|
| 121 |
Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery
|
Roosen, Joey
|
|
|
49 |
Suppl 1 |
p. 4705-4715
|
artikel
|
| 122 |
Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience
|
Tan, Hui
|
|
|
49 |
Suppl 1 |
p. 1002-1011
|
artikel
|
| 123 |
In vivo detection of hydrogen sulfide in the brain of live mouse: application in neuroinflammation models
|
Nam, Bora
|
|
|
49 |
Suppl 1 |
p. 4073-4087
|
artikel
|
| 124 |
Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
|
Piccardo, Arnoldo
|
|
|
49 |
Suppl 1 |
p. 3852-3869
|
artikel
|
| 125 |
Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre
|
Herrmann, Ken
|
|
|
49 |
Suppl 1 |
p. 2300-2309
|
artikel
|
| 126 |
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0
|
Lopci, E.
|
|
|
49 |
Suppl 1 |
p. 2323-2341
|
artikel
|
| 127 |
Longitudinal evaluation of five nasopharyngeal carcinoma animal models on the microPET/MR platform
|
Shi, Jingjing
|
|
|
49 |
Suppl 1 |
p. 1497-1507
|
artikel
|
| 128 |
Long-term test-retest of cerebral [18F]MK-6240 binding and longitudinal evaluation of extracerebral tracer uptake in healthy controls and amnestic MCI patients
|
Vanderlinden, Greet
|
|
|
49 |
Suppl 1 |
p. 4580-4588
|
artikel
|
| 129 |
Low-dose dobutamine stress gated blood pool SPECT assessment of left ventricular contractile reserve in ischemic cardiomyopathy: a feasibility study
|
Shipulin, Vladimir V.
|
|
|
49 |
Suppl 1 |
p. 2219-2231
|
artikel
|
| 130 |
Lung cancer with PET/CT-defined occult nodal metastasis yields favourable prognosis and benefits from adjuvant therapy: a multicentre study
|
Deng, Jiajun
|
|
|
49 |
Suppl 1 |
p. 2414-2424
|
artikel
|
| 131 |
177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)
|
Khreish, Fadi
|
|
|
49 |
Suppl 1 |
p. 1075-1085
|
artikel
|
| 132 |
Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on 68 Ga-PSMA-11 PET/CT in patients with primary prostate cancer
|
Yi, Zhilong
|
|
|
49 |
Suppl 1 |
p. 1523-1534
|
artikel
|
| 133 |
Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
|
Hartrampf, Philipp E.
|
|
|
49 |
Suppl 1 |
p. 3269-3276
|
artikel
|
| 134 |
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease
|
Hartrampf, Philipp E.
|
|
|
49 |
Suppl 1 |
p. 4727-4735
|
artikel
|
| 135 |
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
|
Gafita, Andrei
|
|
|
49 |
Suppl 1 |
p. 4271-4281
|
artikel
|
| 136 |
Modelling [18F]LW223 PET data using simplified imaging protocols for quantification of TSPO expression in the rat heart and brain
|
MacAskill, Mark G.
|
|
|
49 |
Suppl 1 |
p. 137-145
|
artikel
|
| 137 |
Monoamine oxidase binding not expected to significantly affect [18F]flortaucipir PET interpretation
|
Wright, Justin P.
|
|
|
49 |
Suppl 1 |
p. 3797-3808
|
artikel
|
| 138 |
Multi-antitumor therapy and synchronous imaging monitoring based on exosome
|
Qian, Ruijie
|
|
|
49 |
Suppl 1 |
p. 2668-2681
|
artikel
|
| 139 |
Multi-phase contrast-enhanced magnetic resonance image-based radiomics-combined machine learning reveals microscopic ultra-early hepatocellular carcinoma lesions
|
Sun, Kui
|
|
|
49 |
Suppl 1 |
p. 2917-2928
|
artikel
|
| 140 |
NEMA NU 2–2018 performance evaluation of a new generation 30-cm axial field-of-view Discovery MI PET/CT
|
Zeimpekis, Konstantinos G.
|
|
|
49 |
Suppl 1 |
p. 3023-3032
|
artikel
|
| 141 |
Noninvasive assessment of coronary microvascular dysfunction using SPECT myocardial perfusion imaging and myocardial perfusion entropy quantification in a rodent model of type 2 diabetes
|
Carabelli, Adrien
|
|
|
49 |
Suppl 1 |
p. 809-820
|
artikel
|
| 142 |
Non-invasive quantification of acute macrophagic lung inflammation with [11C](R)-PK11195 using a three-tissue compartment kinetic model in experimental acute respiratory distress syndrome
|
Bitker, Laurent
|
|
|
49 |
Suppl 1 |
p. 2122-2136
|
artikel
|
| 143 |
Non-prostate cancer tumours: incidence on 18F-DCFPyL PSMA PET/CT and uptake characteristics in 1445 patients
|
Perry, Elisa
|
|
|
49 |
Suppl 1 |
p. 3277-3288
|
artikel
|
| 144 |
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
|
Heinze, Britta
|
|
|
49 |
Suppl 1 |
p. 301-310
|
artikel
|
| 145 |
Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer—phase I/II study
|
Lin, Yan-Song
|
|
|
49 |
Suppl 1 |
p. 4171-4181
|
artikel
|
| 146 |
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
|
Rogowski, Paul
|
|
|
49 |
Suppl 1 |
p. 1417-1428
|
artikel
|
| 147 |
Patients’ findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT
|
Sollini, Martina
|
|
|
49 |
Suppl 1 |
p. 791-795
|
artikel
|
| 148 |
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival
|
Fiz, Francesco
|
|
|
49 |
Suppl 1 |
p. 3387-3400
|
artikel
|
| 149 |
PET/CT imaging of CSF1R in a mouse model of tuberculosis
|
Foss, Catherine A.
|
|
|
49 |
Suppl 1 |
p. 4088-4096
|
artikel
|
| 150 |
Pharmacokinetic and pharmacodynamic assessment of histamine H3 receptor occupancy by enerisant: a human PET study with a novel H3 binding ligand, [11C]TASP457
|
Kimura, Yasuyuki
|
|
|
49 |
Suppl 1 |
p. 1127-1135
|
artikel
|
| 151 |
Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation
|
Kuroda, Rie
|
|
|
49 |
Suppl 1 |
p. 1574-1583
|
artikel
|
| 152 |
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
|
Sundlöv, Anna
|
|
|
49 |
Suppl 1 |
p. 3830-3840
|
artikel
|
| 153 |
Positive [18F]fluoroethyltyrosine PET/MRI in suspected recurrence of growth hormone–producing pituitary adenoma in a paediatric patient
|
Veldhuijzen van Zanten, Sophie E. M.
|
|
|
49 |
Suppl 1 |
p. 410-411
|
artikel
|
| 154 |
Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer
|
Pang, Yizhen
|
|
|
49 |
Suppl 1 |
p. 1322-1337
|
artikel
|
| 155 |
Preclinical and clinical study on [18F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer’s disease
|
Xu, MiaoMiao
|
|
|
49 |
Suppl 1 |
p. 652-663
|
artikel
|
| 156 |
Preclinical and first-in-human evaluation of 18F-labeled D-peptide antagonist for PD-L1 status imaging with PET
|
Zhou, Ming
|
|
|
49 |
Suppl 1 |
p. 4312-4324
|
artikel
|
| 157 |
Preclinical characterization of [18F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase
|
Koike, Tatsuki
|
|
|
49 |
Suppl 1 |
p. 1148-1156
|
artikel
|
| 158 |
Preclinical evaluation and pilot clinical study of [18F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis
|
Ge, Luna
|
|
|
49 |
Suppl 1 |
p. 4025-4036
|
artikel
|
| 159 |
Preclinical evaluation of (S)-[18F]GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971
|
Ramakrishnan, Nisha K.
|
|
|
49 |
Suppl 1 |
p. 125-136
|
artikel
|
| 160 |
Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer
|
Azari, Feredun
|
|
|
49 |
Suppl 1 |
p. 4406-4418
|
artikel
|
| 161 |
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
|
Roberts, Matthew J.
|
|
|
49 |
Suppl 1 |
p. 3289-3294
|
artikel
|
| 162 |
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study
|
Cistaro, Angelina
|
|
|
49 |
Suppl 1 |
p. 1374-1385
|
artikel
|
| 163 |
Prognostic value of regional myocardial flow reserve derived from 13N-ammonia positron emission tomography in patients with suspected coronary artery disease
|
von Felten, Elia
|
|
|
49 |
Suppl 1 |
p. 311-320
|
artikel
|
| 164 |
Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study
|
Bodar, Yves J. L.
|
|
|
49 |
Suppl 1 |
p. 1731-1742
|
artikel
|
| 165 |
Prospective intra-individual blinded comparison of [18F]PSMA-1007 and [68 Ga]Ga-PSMA-11 PET/CT imaging in patients with confirmed prostate cancer
|
Pattison, David A.
|
|
|
49 |
Suppl 1 |
p. 763-776
|
artikel
|
| 166 |
P2X7 receptor-specific radioligand 18F-FTTM for atherosclerotic plaque PET imaging
|
Fu, Zhequan
|
|
|
49 |
Suppl 1 |
p. 2595-2604
|
artikel
|
| 167 |
Quantitative classification and radiomics of [18F]FDG-PET/CT in indeterminate thyroid nodules
|
de Koster, Elizabeth J.
|
|
|
49 |
Suppl 1 |
p. 2174-2188
|
artikel
|
| 168 |
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
|
Hribernik, Nežka
|
|
|
49 |
Suppl 1 |
p. 1857-1869
|
artikel
|
| 169 |
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine
|
van der Heide, Circe D.
|
|
|
49 |
Suppl 1 |
p. 4616-4641
|
artikel
|
| 170 |
Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism
|
Lee, Sang Hee
|
|
|
49 |
Suppl 1 |
p. 110-124
|
artikel
|
| 171 |
Regional glucose metabolic decreases with ageing are associated with microstructural white matter changes: a simultaneous PET/MR study
|
van Aalst, June
|
|
|
49 |
Suppl 1 |
p. 664-680
|
artikel
|
| 172 |
Reproducibility of quantitative coronary calcium scoring from PET/CT attenuation maps: comparison to ECG-gated CT scans
|
Pieszko, Konrad
|
|
|
49 |
Suppl 1 |
p. 4122-4132
|
artikel
|
| 173 |
Retrospective analysis of PSMA PET/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment/outcome in a tertiary cancer referral center and University Medical Center
|
Piek, Marceline W.
|
|
|
49 |
Suppl 1 |
p. 2392-2400
|
artikel
|
| 174 |
RGD-functionalised melanin nanoparticles for intraoperative photoacoustic imaging-guided breast cancer surgery
|
Liu, Jing-Jing
|
|
|
49 |
Suppl 1 |
p. 847-860
|
artikel
|
| 175 |
Role of a portable gamma-camera with optical view for margins assessment of pulmonary nodules resected by radioguided surgery
|
Vollmer, Ivan
|
|
|
49 |
Suppl 1 |
p. 361-370
|
artikel
|
| 176 |
Role of sex hormones in modulating myocardial perfusion and coronary flow reserve
|
Haider, Achi
|
|
|
49 |
Suppl 1 |
p. 2209-2218
|
artikel
|
| 177 |
Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity
|
Ruigrok, Eline A. M.
|
|
|
49 |
Suppl 1 |
p. 4440-4451
|
artikel
|
| 178 |
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
|
Reinecke, Maximilian J.
|
|
|
49 |
Suppl 1 |
p. 3247-3256
|
artikel
|
| 179 |
Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics
|
Kim, Seok
|
|
|
49 |
Suppl 1 |
p. 3547-3556
|
artikel
|
| 180 |
SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management—the EANM perspective
|
Petranović Ovčariček, Petra
|
|
|
49 |
Suppl 1 |
p. 3959-3963
|
artikel
|
| 181 |
Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement
|
Kesler, Mikhail
|
|
|
49 |
Suppl 1 |
p. 2077-2085
|
artikel
|
| 182 |
Synthesis, preclinical evaluation, and first-in-human study of Al18F-PSMA-Q for prostate cancer imaging
|
Wu, Yitian
|
|
|
49 |
Suppl 1 |
p. 2774-2785
|
artikel
|
| 183 |
Targeting visualization of malignant tumor based on the alteration of DWI signal generated by hTERT promoter–driven AQP1 overexpression
|
Zhang, Liang
|
|
|
49 |
Suppl 1 |
p. 2310-2322
|
artikel
|
| 184 |
The added value of PSMA PET/MR radiomics for prostate cancer staging
|
Solari, Esteban Lucas
|
|
|
49 |
Suppl 1 |
p. 527-538
|
artikel
|
| 185 |
The cultivation of supply side data science in medical imaging: an opportunity to define the future of global health
|
Kesner, Adam
|
|
|
49 |
Suppl 1 |
p. 436-442
|
artikel
|
| 186 |
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma
|
Andersen, Jesper A. S.
|
|
|
49 |
Suppl 1 |
p. 2342-2351
|
artikel
|
| 187 |
The “digital biopsy” in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT
|
Monaco, Lavinia
|
|
|
49 |
Suppl 1 |
p. 3401-3411
|
artikel
|
| 188 |
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study
|
Caldarella, Carmelo
|
|
|
49 |
Suppl 1 |
p. 1623-1629
|
artikel
|
| 189 |
The integrated nuclear medicine and radiology residency program in the Netherlands: strengths and potential areas for improvement according to nuclear medicine physicians and radiologists
|
Velleman, Ton
|
|
|
49 |
Suppl 1 |
p. 3016-3022
|
artikel
|
| 190 |
The optimal 18F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth
|
Gertsenshteyn, Inna
|
|
|
49 |
Suppl 1 |
p. 4014-4024
|
artikel
|
| 191 |
The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent—comparison with [18F]FDG
|
Lan, Lianjun
|
|
|
49 |
Suppl 1 |
p. 963-979
|
artikel
|
| 192 |
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study)
|
Bauckneht, Matteo
|
|
|
49 |
Suppl 1 |
p. 1063-1074
|
artikel
|
| 193 |
The prognostic value of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: comparison of visual Deauville criteria and a lesion-to-liver SUVmax ratio-based evaluation system
|
Li, Ying-He
|
|
|
49 |
Suppl 1 |
p. 1311-1321
|
artikel
|
| 194 |
The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study
|
Yang, Guangjie
|
|
|
49 |
Suppl 1 |
p. 2949-2959
|
artikel
|
| 195 |
The role of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma
|
Wang, Xiaoyan
|
|
|
49 |
Suppl 1 |
p. 4241-4251
|
artikel
|
| 196 |
The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review
|
Kiamanesh, Zahra
|
|
|
49 |
Suppl 1 |
p. 4661-4676
|
artikel
|
| 197 |
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA
|
Backhaus, P.
|
|
|
49 |
Suppl 1 |
p. 1822-1832
|
artikel
|
| 198 |
Trimodality therapy for locally advanced esophageal squamous cell carcinoma: the role of volume-based PET/CT in patient management and prognostication
|
Choi, Yeonu
|
|
|
49 |
Suppl 1 |
p. 751-762
|
artikel
|
| 199 |
Ultrafast 30-s total-body PET/CT scan: a preliminary study
|
Zhang, Yiqiu
|
|
|
49 |
Suppl 1 |
p. 2504-2513
|
artikel
|
| 200 |
Usefulness of brain FDG PET/CT imaging in pediatric patients with suspected autoimmune encephalitis from a prospective study
|
Yin, Yafu
|
|
|
49 |
Suppl 1 |
p. 1918-1929
|
artikel
|
| 201 |
Visualization of thermal damage using 68 Ga-FAPI-PET/CT after pulmonary vein isolation
|
Kupusovic, Jana
|
|
|
49 |
Suppl 1 |
p. 1553-1559
|
artikel
|
| 202 |
Visualizing dynamic changes in PD-L1 expression in non-small cell lung carcinoma with radiolabeled recombinant human PD-1
|
Luo, Haiming
|
|
|
49 |
Suppl 1 |
p. 2735-2745
|
artikel
|
| 203 |
What value can TSPO PET bring for epilepsy treatment?
|
Bouilleret, Viviane
|
|
|
49 |
Suppl 1 |
p. 221-233
|
artikel
|
| 204 |
Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET/CT using dual-tracer learning
|
Capobianco, Nicolò
|
|
|
49 |
Suppl 1 |
p. 517-526
|
artikel
|
Tijdschrift beschrijving